YARROW BIOSCIENCE, INC. Investments and Cash
YARROW BIOSCIENCE, INC. (YARW) had Investments and Cash of $76.90 million as of 2019-12-31, per its 10-K filed 2020-03-03.
Discontinued › Balance Sheet › Assets
us-gaap:InvestmentsAndCash · last filed 2020-03-03
- 2019-12-31: Investments and Cash $76.90M.
- 2019-09-30: Investments and Cash $93.40M.
- 2019-06-30: Investments and Cash $109.40M.
- 2019-03-31: Investments and Cash $121.50M.
| Period end | Investments and Cash |
|---|---|
| 2019-12-31 | $76.90M 10-K · filed 2020-03-03 |
| 2019-09-30 | $93.40M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $109.40M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $121.50M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $136.30M 10-K · filed 2019-02-28 |
| 2018-09-30 | $152.70M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $164.20M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $176.60M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $62.50M 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |